APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antidepressants

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Antidepressants Industry Growth and Trends Forecast to 2032

29 December 2025105 pages

Choose your research edition.

Industry ResearchAntidepressants Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Antidepressants Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Antidepressants Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antidepressants Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Antidepressants Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Antidepressants market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Antidepressants is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Antidepressants is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antidepressants is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Antidepressants include Bristol-Myers Squibb Company, H Lundbeck, Sun Pharmaceuticals, Astrazeneca, GlaxoSmithKline, Pfizer Inc., Eli Lilly and Company, Merck and Johnson & Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Antidepressants market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Antidepressants market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Antidepressants market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Antidepressants.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Antidepressants market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Antidepressants Market by Company

Bristol-Myers Squibb Company

H Lundbeck

Sun Pharmaceuticals

Astrazeneca

GlaxoSmithKline

Pfizer Inc.

Eli Lilly and Company

Merck

Johnson & Johnson

Sanofi

Antidepressants Segment by Type

Benzodiazepines

Monoamine Oxidase Inhibitors

Antipsychotics

Tricyclic Antidepressants

Novel Agents

Selective Norepinephrine Reuptake Inhibitors

Selective Serotonin Reuptake Inhibitors

Antidepressants Segment by Application

Hospitals

Clinics

Other

Antidepressants Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antidepressants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antidepressants and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antidepressants.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Antidepressants manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Antidepressants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Benzodiazepines Table 2. Major Company of Monoamine Oxidase Inhibitors Table 3. Major Company of Antipsychotics Table 4. Major Company of Tricyclic Antidepressants Table 5. Major Company of Novel Agents Table 6. Major Company of Selective Norepinephrine Reuptake Inhibitors Table 7. Major Company of Selective Serotonin Reuptake Inhibitors Table 8. Global Antidepressants Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 9. Global Antidepressants Sales by Type (2021-2026) & (W Units) Table 10. Global Antidepressants Sales Market Share in Volume by Type (2021-2026) Table 11. Global Antidepressants Sales by Type (2021-2026) & (US$ Million) Table 12. Global Antidepressants Sales Market Share in Value by Type (2021-2026) Table 13. Global Antidepressants Price by Type (2021-2026) & (US$/Unit) Table 14. Global Antidepressants Sales by Type (2027-2032) & (W Units) Table 15. Global Antidepressants Sales Market Share in Volume by Type (2027-2032) Table 16. Global Antidepressants Sales by Type (2027-2032) & (US$ Million) Table 17. Global Antidepressants Sales Market Share in Value by Type (2027-2032) Table 18. Global Antidepressants Price by Type (2027-2032) & (US$/Unit) Table 19. North America Antidepressants Sales by Type (2021-2026) & (W Units) Table 20. North America Antidepressants Sales by Type (2021-2026) & (US$ Million) Table 21. Europe Antidepressants Sales by Type (2021-2026) & (W Units) Table 22. Europe Antidepressants Sales by Type (2021-2026) & (US$ Million) Table 23. Asia-Pacific Antidepressants Sales by Type (2021-2026) & (W Units) Table 24. Asia-Pacific Antidepressants Sales by Type (2021-2026) & (US$ Million) Table 25. Latin America Antidepressants Sales by Type (2021-2026) & (W Units) Table 26. Latin America Antidepressants Sales by Type (2021-2026) & (US$ Million) Table 27. Middle East and Africa Antidepressants Sales by Type (2021-2026) & (W Units) Table 28. Middle East and Africa Antidepressants Sales by Type (2021-2026) & (US$ Million) Table 29. Antidepressants Industry Trends Table 30. Antidepressants Industry Drivers Table 31. Antidepressants Industry Opportunities and Challenges Table 32. Antidepressants Industry Restraints Table 33. Global Antidepressants Sales Revenue by Company (US$ Million) & (2021-2026) Table 34. Global Antidepressants Revenue Market Share by Company (2021-2026) Table 35. Global Antidepressants Sales by Company (2021-2026) & (W Units) Table 36. Global Antidepressants Sales Share by Company (2021-2026) Table 37. Global Antidepressants Market Price by Company (2021-2026) & (US$/Unit) Table 38. Global Antidepressants Industry Company Ranking, 2024 VS 2025 VS 2026 Table 39. Global Antidepressants Major Company Production Sites and Headquarters Table 40. Global Antidepressants Company, Product Type & Application Table 41. Global Antidepressants Company Establishment Date Table 42. Global Company Market Concentration Ratio (CR5 and HHI) Table 43. Global Antidepressants by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 44. Global Antidepressants Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 45. Global Antidepressants Sales by Region (2021-2026) & (W Units) Table 46. Global Antidepressants Sales Market Share in Volume by Region (2021-2026) Table 47. Global Antidepressants Sales by Region (2021-2026) & (US$ Million) Table 48. Global Antidepressants Sales Market Share in Value by Region (2021-2026) Table 49. Global Antidepressants Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 50. Global Antidepressants Sales by Region (2027-2032) & (W Units) Table 51. Global Antidepressants Sales Market Share in Volume by Region (2027-2032) Table 52. Global Antidepressants Sales by Region (2027-2032) & (US$ Million) Table 53. Global Antidepressants Sales Market Share in Value by Region (2027-2032) Table 54. Global Antidepressants Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 55. Global Antidepressants Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 56. Global Antidepressants Sales by Application (2021-2026) & (W Units) Table 57. Global Antidepressants Sales Market Share in Volume by Application (2021-2026) Table 58. Global Antidepressants Sales by Application (2021-2026) & (US$ Million) Table 59. Global Antidepressants Sales Market Share in Value by Application (2021-2026) Table 60. Global Antidepressants Price by Application (2021-2026) & (US$/Unit) Table 61. Global Antidepressants Sales by Application (2027-2032) & (W Units) Table 62. Global Antidepressants Sales Market Share in Volume by Application (2027-2032) Table 63. Global Antidepressants Sales by Application (2027-2032) & (US$ Million) Table 64. Global Antidepressants Sales Market Share in Value by Application (2027-2032) Table 65. Global Antidepressants Price by Application (2027-2032) & (US$/Unit) Table 66. North America Antidepressants Sales by Application (2021-2026) & (W Units) Table 67. North America Antidepressants Sales by Application (2021-2026) & (US$ Million) Table 68. Europe Antidepressants Sales by Application (2021-2026) & (W Units) Table 69. Europe Antidepressants Sales by Application (2021-2026) & (US$ Million) Table 70. Asia-Pacific Antidepressants Sales by Application (2021-2026) & (W Units) Table 71. Asia-Pacific Antidepressants Sales by Application (2021-2026) & (US$ Million) Table 72. Latin America Antidepressants Sales by Application (2021-2026) & (W Units) Table 73. Latin America Antidepressants Sales by Application (2021-2026) & (US$ Million) Table 74. Middle East and Africa Antidepressants Sales by Application (2021-2026) & (W Units) Table 75. Middle East and Africa Antidepressants Sales by Application (2021-2026) & (US$ Million) Table 76. Bristol-Myers Squibb Company Company Information Table 77. Bristol-Myers Squibb Company Business Overview Table 78. Bristol-Myers Squibb Company Antidepressants Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Bristol-Myers Squibb Company Antidepressants Product Portfolio Table 80. Bristol-Myers Squibb Company Recent Development Table 81. H Lundbeck Company Information Table 82. H Lundbeck Business Overview Table 83. H Lundbeck Antidepressants Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. H Lundbeck Antidepressants Product Portfolio Table 85. H Lundbeck Recent Development Table 86. Sun Pharmaceuticals Company Information Table 87. Sun Pharmaceuticals Business Overview Table 88. Sun Pharmaceuticals Antidepressants Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Sun Pharmaceuticals Antidepressants Product Portfolio Table 90. Sun Pharmaceuticals Recent Development Table 91. Astrazeneca Company Information Table 92. Astrazeneca Business Overview Table 93. Astrazeneca Antidepressants Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Astrazeneca Antidepressants Product Portfolio Table 95. Astrazeneca Recent Development Table 96. GlaxoSmithKline Company Information Table 97. GlaxoSmithKline Business Overview Table 98. GlaxoSmithKline Antidepressants Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. GlaxoSmithKline Antidepressants Product Portfolio Table 100. GlaxoSmithKline Recent Development Table 101. Pfizer Inc. Company Information Table 102. Pfizer Inc. Business Overview Table 103. Pfizer Inc. Antidepressants Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Pfizer Inc. Antidepressants Product Portfolio Table 105. Pfizer Inc. Recent Development Table 106. Eli Lilly and Company Company Information Table 107. Eli Lilly and Company Business Overview Table 108. Eli Lilly and Company Antidepressants Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Eli Lilly and Company Antidepressants Product Portfolio Table 110. Eli Lilly and Company Recent Development Table 111. Merck Company Information Table 112. Merck Business Overview Table 113. Merck Antidepressants Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Merck Antidepressants Product Portfolio Table 115. Merck Recent Development Table 116. Johnson & Johnson Company Information Table 117. Johnson & Johnson Business Overview Table 118. Johnson & Johnson Antidepressants Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Johnson & Johnson Antidepressants Product Portfolio Table 120. Johnson & Johnson Recent Development Table 121. Sanofi Company Information Table 122. Sanofi Business Overview Table 123. Sanofi Antidepressants Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Sanofi Antidepressants Product Portfolio Table 125. Sanofi Recent Development Table 126. North America Antidepressants Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 127. North America Antidepressants Sales by Country (2021-2026) & (W Units) Table 128. North America Antidepressants Sales Market Share by Country (2021-2026) Table 129. North America Antidepressants Sales Forecast by Country (2027-2032) & (W Units) Table 130. North America Antidepressants Sales Market Share Forecast by Country (2027-2032) Table 131. North America Antidepressants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. North America Antidepressants Market Size by Country (2021-2026) & (US$ Million) Table 133. North America Antidepressants Market Share by Country (2021-2026) Table 134. North America Antidepressants Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. North America Antidepressants Market Share Forecast by Country (2027-2032) Table 136. Europe Antidepressants Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 137. Europe Antidepressants Sales by Country (2021-2026) & (W Units) Table 138. Europe Antidepressants Sales Market Share by Country (2021-2026) Table 139. Europe Antidepressants Sales Forecast by Country (2027-2032) & (W Units) Table 140. Europe Antidepressants Sales Market Share Forecast by Country (2027-2032) Table 141. Europe Antidepressants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Europe Antidepressants Market Size by Country (2021-2026) & (US$ Million) Table 143. Europe Antidepressants Market Share by Country (2021-2026) Table 144. Europe Antidepressants Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Europe Antidepressants Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Antidepressants Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Antidepressants Sales by Country (2021-2026) & (W Units) Table 148. Asia-Pacific Antidepressants Sales Market Share by Country (2021-2026) Table 149. Asia-Pacific Antidepressants Sales Forecast by Country (2027-2032) & (W Units) Table 150. Asia-Pacific Antidepressants Sales Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Antidepressants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Antidepressants Market Size by Country (2021-2026) & (US$ Million) Table 153. Asia-Pacific Antidepressants Market Share by Country (2021-2026) Table 154. Asia-Pacific Antidepressants Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Asia-Pacific Antidepressants Market Share Forecast by Country (2027-2032) Table 156. Latin America Antidepressants Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 157. Latin America Antidepressants Sales by Country (2021-2026) & (W Units) Table 158. Latin America Antidepressants Sales Market Share by Country (2021-2026) Table 159. Latin America Antidepressants Sales Forecast by Country (2027-2032) & (W Units) Table 160. Latin America Antidepressants Sales Market Share Forecast by Country (2027-2032) Table 161. Latin America Antidepressants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Latin America Antidepressants Market Size by Country (2021-2026) & (US$ Million) Table 163. Latin America Antidepressants Market Share by Country (2021-2026) Table 164. Latin America Antidepressants Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Latin America Antidepressants Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Antidepressants Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Antidepressants Sales by Country (2021-2026) & (W Units) Table 168. Middle East and Africa Antidepressants Sales Market Share by Country (2021-2026) Table 169. Middle East and Africa Antidepressants Sales Forecast by Country (2027-2032) & (W Units) Table 170. Middle East and Africa Antidepressants Sales Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Antidepressants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Antidepressants Market Size by Country (2021-2026) & (US$ Million) Table 173. Middle East and Africa Antidepressants Market Share by Country (2021-2026) Table 174. Middle East and Africa Antidepressants Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Middle East and Africa Antidepressants Market Share Forecast by Country (2027-2032) Table 176. Key Raw Materials Table 177. Raw Materials Key Suppliers Table 178. Antidepressants Distributors List Table 179. Antidepressants Customers List Table 180. Research Programs/Design for This Report Table 181. Authors List of This Report Table 182. Secondary Sources Table 183. Primary Sources List of Figures Figure 1. Antidepressants Image Figure 2. Global Antidepressants Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antidepressants Market Size (2021-2032) & (US$ Million) Figure 4. Global Antidepressants Sales (2021-2032) & (W Units) Figure 5. Benzodiazepines Image Figure 6. Global Benzodiazepines Sales YoY Growth (2021-2032) & (W Units) Figure 7. Monoamine Oxidase Inhibitors Image Figure 8. Global Monoamine Oxidase Inhibitors Sales YoY Growth (2021-2032) & (W Units) Figure 9. Antipsychotics Image Figure 10. Global Antipsychotics Sales YoY Growth (2021-2032) & (W Units) Figure 11. Tricyclic Antidepressants Image Figure 12. Global Tricyclic Antidepressants Sales YoY Growth (2021-2032) & (W Units) Figure 13. Novel Agents Image Figure 14. Global Novel Agents Sales YoY Growth (2021-2032) & (W Units) Figure 15. Selective Norepinephrine Reuptake Inhibitors Image Figure 16. Global Selective Norepinephrine Reuptake Inhibitors Sales YoY Growth (2021-2032) & (W Units) Figure 17. Selective Serotonin Reuptake Inhibitors Image Figure 18. Global Selective Serotonin Reuptake Inhibitors Sales YoY Growth (2021-2032) & (W Units) Figure 19. Global Antidepressants Market Size Overview by Type (2021-2032) & (US$ Million) Figure 20. Global Antidepressants Market Share by Type 2025 VS 2032 Figure 21. North America Antidepressants Sales Market Share in Volume by Type in 2025 Figure 22. North America Antidepressants Sales Market Share in Value by Type in 2025 Figure 23. Europe Antidepressants Sales Market Share in Volume by Type in 2025 Figure 24. Europe Antidepressants Sales Market Share in Value by Type in 2025 Figure 25. Asia-Pacific Antidepressants Sales Market Share in Volume by Type in 2025 Figure 26. Asia-Pacific Antidepressants Sales Market Share in Value by Type in 2025 Figure 27. Latin America Antidepressants Sales Market Share in Volume by Type in 2025 Figure 28. Latin America Antidepressants Sales Market Share in Value by Type in 2025 Figure 29. Middle East and Africa Antidepressants Sales Market Share in Volume by Type in 2025 Figure 30. Middle East and Africa Antidepressants Sales Market Share in Value by Type in 2025 Figure 31. Global Top 5 and 10 Antidepressants Players Market Share by Revenue in 2025 Figure 32. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 33. Hospitals Image Figure 34. Global Hospitals Sales YoY Growth (2021-2032) & (W Units) Figure 35. Clinics Image Figure 36. Global Clinics Sales YoY Growth (2021-2032) & (W Units) Figure 37. Other Image Figure 38. Global Other Sales YoY Growth (2021-2032) & (W Units) Figure 39. Global Antidepressants Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Antidepressants Market Share by Application 2025 VS 2032 Figure 41. North America Antidepressants Sales Market Share in Volume by Application in 2025 Figure 42. North America Antidepressants Sales Market Share in Value by Application in 2025 Figure 43. Europe Antidepressants Sales Market Share in Volume by Application in 2025 Figure 44. Europe Antidepressants Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Antidepressants Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Antidepressants Sales Market Share in Value by Application in 2025 Figure 47. Latin America Antidepressants Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Antidepressants Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Antidepressants Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Antidepressants Sales Market Share in Value by Application in 2025 Figure 51. North America Antidepressants Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. North America Antidepressants Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Antidepressants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Antidepressants Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Antidepressants Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Europe Antidepressants Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Antidepressants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Antidepressants Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Antidepressants Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 60. Asia-Pacific Antidepressants Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Antidepressants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Antidepressants Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Antidepressants Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 64. Latin America Antidepressants Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Antidepressants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Antidepressants Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Antidepressants Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 68. Middle East and Africa Antidepressants Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Antidepressants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Antidepressants Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Antidepressants Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Antidepressants Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Benzodiazepines
  • Monoamine Oxidase Inhibitors
  • Antipsychotics
  • Tricyclic Antidepressants
  • Novel Agents
  • Selective Norepinephrine Reuptake Inhibitors
  • Selective Serotonin Reuptake Inhibitors
Applications
  • Hospitals
  • Clinics
  • Other
Companies covered
  • Bristol-Myers Squibb Company
  • H Lundbeck
  • Sun Pharmaceuticals
  • Astrazeneca
  • GlaxoSmithKline
  • Pfizer Inc.
  • Eli Lilly and Company
  • Merck
  • Johnson & Johnson
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Antidepressants Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Antidepressants Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Antidepressants Market by Type
  6. 1.3.1 Benzodiazepines
  7. 1.3.2 Monoamine Oxidase Inhibitors
  8. 1.3.3 Antipsychotics
  9. 1.3.4 Tricyclic Antidepressants
  10. 1.3.5 Novel Agents
  11. 1.3.6 Selective Norepinephrine Reuptake Inhibitors
  12. 1.3.7 Selective Serotonin Reuptake Inhibitors
  13. 1.4 Global Antidepressants Market Size by Type
  14. 1.4.1 Global Antidepressants Market Size Overview by Type (2021-2032)
  15. 1.4.2 Global Antidepressants Historic Market Size Review by Type (2021-2026)
  16. 1.4.3 Global Antidepressants Forecasted Market Size by Type (2027-2032)
  17. 1.5 Key Regions Market Size by Type
  18. 1.5.1 North America Antidepressants Sales Breakdown by Type (2021-2026)
  19. 1.5.2 Europe Antidepressants Sales Breakdown by Type (2021-2026)
  20. 1.5.3 Asia-Pacific Antidepressants Sales Breakdown by Type (2021-2026)
  21. 1.5.4 South America Antidepressants Sales Breakdown by Type (2021-2026)
  22. 1.5.5 Middle East and Africa Antidepressants Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Antidepressants Industry Trends
  2. 2.2 Antidepressants Industry Drivers
  3. 2.3 Antidepressants Industry Opportunities and Challenges
  4. 2.4 Antidepressants Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Antidepressants Revenue (2021-2026)
  2. 3.2 Global Top Players by Antidepressants Sales (2021-2026)
  3. 3.3 Global Top Players by Antidepressants Price (2021-2026)
  4. 3.4 Global Antidepressants Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Antidepressants Major Company Production Sites & Headquarters
  6. 3.6 Global Antidepressants Company, Product Type & Application
  7. 3.7 Global Antidepressants Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Antidepressants Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Antidepressants Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Antidepressants Tier 1, Tier 2, and Tier 3
4 Antidepressants Regional Status and Outlook
  1. 4.1 Global Antidepressants Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Antidepressants Historic Market Size by Region
  3. 4.2.1 Global Antidepressants Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Antidepressants Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Antidepressants Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Antidepressants Forecasted Market Size by Region
  7. 4.3.1 Global Antidepressants Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Antidepressants Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Antidepressants Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Antidepressants by Application
  1. 5.1 Antidepressants Market by Application
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Other
  5. 5.2 Global Antidepressants Market Size by Application
  6. 5.2.1 Global Antidepressants Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Antidepressants Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Antidepressants Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Antidepressants Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Antidepressants Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Antidepressants Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Antidepressants Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Antidepressants Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Bristol-Myers Squibb Company
  2. 6.1.1 Bristol-Myers Squibb Company Company Information
  3. 6.1.2 Bristol-Myers Squibb Company Business Overview
  4. 6.1.3 Bristol-Myers Squibb Company Antidepressants Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Bristol-Myers Squibb Company Antidepressants Product Portfolio
  6. 6.1.5 Bristol-Myers Squibb Company Recent Developments
  7. 6.2 H Lundbeck
  8. 6.2.1 H Lundbeck Company Information
  9. 6.2.2 H Lundbeck Business Overview
  10. 6.2.3 H Lundbeck Antidepressants Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 H Lundbeck Antidepressants Product Portfolio
  12. 6.2.5 H Lundbeck Recent Developments
  13. 6.3 Sun Pharmaceuticals
  14. 6.3.1 Sun Pharmaceuticals Company Information
  15. 6.3.2 Sun Pharmaceuticals Business Overview
  16. 6.3.3 Sun Pharmaceuticals Antidepressants Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sun Pharmaceuticals Antidepressants Product Portfolio
  18. 6.3.5 Sun Pharmaceuticals Recent Developments
  19. 6.4 Astrazeneca
  20. 6.4.1 Astrazeneca Company Information
  21. 6.4.2 Astrazeneca Business Overview
  22. 6.4.3 Astrazeneca Antidepressants Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Astrazeneca Antidepressants Product Portfolio
  24. 6.4.5 Astrazeneca Recent Developments
  25. 6.5 GlaxoSmithKline
  26. 6.5.1 GlaxoSmithKline Company Information
  27. 6.5.2 GlaxoSmithKline Business Overview
  28. 6.5.3 GlaxoSmithKline Antidepressants Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 GlaxoSmithKline Antidepressants Product Portfolio
  30. 6.5.5 GlaxoSmithKline Recent Developments
  31. 6.6 Pfizer Inc.
  32. 6.6.1 Pfizer Inc. Company Information
  33. 6.6.2 Pfizer Inc. Business Overview
  34. 6.6.3 Pfizer Inc. Antidepressants Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer Inc. Antidepressants Product Portfolio
  36. 6.6.5 Pfizer Inc. Recent Developments
  37. 6.7 Eli Lilly and Company
  38. 6.7.1 Eli Lilly and Company Company Information
  39. 6.7.2 Eli Lilly and Company Business Overview
  40. 6.7.3 Eli Lilly and Company Antidepressants Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Eli Lilly and Company Antidepressants Product Portfolio
  42. 6.7.5 Eli Lilly and Company Recent Developments
  43. 6.8 Merck
  44. 6.8.1 Merck Company Information
  45. 6.8.2 Merck Business Overview
  46. 6.8.3 Merck Antidepressants Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Merck Antidepressants Product Portfolio
  48. 6.8.5 Merck Recent Developments
  49. 6.9 Johnson & Johnson
  50. 6.9.1 Johnson & Johnson Company Information
  51. 6.9.2 Johnson & Johnson Business Overview
  52. 6.9.3 Johnson & Johnson Antidepressants Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Johnson & Johnson Antidepressants Product Portfolio
  54. 6.9.5 Johnson & Johnson Recent Developments
  55. 6.10 Sanofi
  56. 6.10.1 Sanofi Company Information
  57. 6.10.2 Sanofi Business Overview
  58. 6.10.3 Sanofi Antidepressants Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Sanofi Antidepressants Product Portfolio
  60. 6.10.5 Sanofi Recent Developments
7 North America by Country
  1. 7.1 North America Antidepressants Sales by Country
  2. 7.1.1 North America Antidepressants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Antidepressants Sales by Country (2021-2026)
  4. 7.1.3 North America Antidepressants Sales Forecast by Country (2027-2032)
  5. 7.2 North America Antidepressants Market Size by Country
  6. 7.2.1 North America Antidepressants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Antidepressants Market Size by Country (2021-2026)
  8. 7.2.3 North America Antidepressants Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Antidepressants Sales by Country
  2. 8.1.1 Europe Antidepressants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Antidepressants Sales by Country (2021-2026)
  4. 8.1.3 Europe Antidepressants Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Antidepressants Market Size by Country
  6. 8.2.1 Europe Antidepressants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Antidepressants Market Size by Country (2021-2026)
  8. 8.2.3 Europe Antidepressants Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Antidepressants Sales by Country
  2. 9.1.1 Asia-Pacific Antidepressants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Antidepressants Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Antidepressants Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Antidepressants Market Size by Country
  6. 9.2.1 Asia-Pacific Antidepressants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Antidepressants Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Antidepressants Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Antidepressants Sales by Country
  2. 10.1.1 South America Antidepressants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Antidepressants Sales by Country (2021-2026)
  4. 10.1.3 South America Antidepressants Sales Forecast by Country (2027-2032)
  5. 10.2 South America Antidepressants Market Size by Country
  6. 10.2.1 South America Antidepressants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Antidepressants Market Size by Country (2021-2026)
  8. 10.2.3 South America Antidepressants Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Antidepressants Sales by Country
  2. 11.1.1 Middle East and Africa Antidepressants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Antidepressants Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Antidepressants Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Antidepressants Market Size by Country
  6. 11.2.1 Middle East and Africa Antidepressants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Antidepressants Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Antidepressants Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Antidepressants Value Chain Analysis
  2. 12.1.1 Antidepressants Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Antidepressants Production Mode & Process
  7. 12.2 Antidepressants Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Antidepressants Distributors
  10. 12.2.3 Antidepressants Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst